We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$15B
AUM Growth
-$64.1M
Cap. Flow
-$674M
Cap. Flow %
-4.48%
Top 10 Hldgs %
8.55%
Holding
1,316
New
82
Increased
373
Reduced
600
Closed
70
Avg Time Held
10.9 quarters
Top 10 Avg Time Held
3.8 quarters
Top 20 Avg Time Held
7.4 quarters

Top Sells

Rank Stock Value
1
CGNX icon
Cognex
CGNX
+$64.3M
2
LDR
Landauer Inc
LDR
+$48.7M
3
MKSI icon
MKS Inc
MKSI
+$39.1M
4
IPGP icon
IPG Photonics
IPGP
+$36.6M
5
CPRT icon
Copart
CPRT
+$34.9M

Sector Composition

Rank Sector Weight
1 Industrials 29.91%
2 Technology 17.71%
3 Consumer Discretionary 16.18%
4 Financials 11.52%
5 Materials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LMNX
1201
DELISTED
Luminex Corp
LMNX
$9K ﹤0.01%
474
+31
+7% +$645
2017 Q3
1 quarter
ACIA
1202
DELISTED
Acacia Communications Inc
ACIA
$9K ﹤0.01%
254
+55
+28% +$2.25K
2017 Q3
1 quarter
MEET
1203
DELISTED
The Meet Group, Inc. Common Stock
MEET
$9K ﹤0.01%
+3,358
New +$9.99K
2017 Q4
0 quarters
ARC icon
1204
DELISTED
ARC Document Solutions, Inc.
ARC
$9K ﹤0.01%
+3,561
New +$11.7K
2017 Q4
0 quarters
SNBC
1205
DELISTED
Sun Bancorp Inc
SNBC
$9K ﹤0.01%
355
+15
+4% +$376
2017 Q3
1 quarter
ANIK icon
1206
Anika Therapeutics
ANIK
$268M
$8K ﹤0.01%
154
+22
+17% +$1.22K
2017 Q3
1 quarter
CTMX icon
1207
CytomX Therapeutics
CTMX
$527M
$8K ﹤0.01%
366
-75
-17% -$1.55K
2017 Q3
1 quarter
CWBC icon
1208
Community West Bancshares
CWBC
$709M
$8K ﹤0.01%
+388
New +$7.94K
2017 Q4
0 quarters
DHX icon
1209
DHI Group
DHX
$213M
$8K ﹤0.01%
4,145
+357
+9% +$740
2017 Q3
1 quarter
EPM icon
1210
Evolution Petroleum
EPM
$149M
$8K ﹤0.01%
1,116
+115
+11% +$808
2017 Q3
1 quarter
ITIC icon
1211
Investors Title Co
ITIC
$548M
$8K ﹤0.01%
41
+2
+5% +$385
2017 Q3
1 quarter
QDEL icon
1212
QuidelOrtho
QDEL
$906M
$8K ﹤0.01%
193
-2
-1% -$82
2017 Q3
1 quarter
RBB icon
1213
RBB Bancorp
RBB
$436M
$8K ﹤0.01%
304
-11
-3% -$272
2017 Q3
1 quarter
USLM icon
1214
United States Lime & Minerals
USLM
$3.11B
$8K ﹤0.01%
505
+45
+10% +$776
2017 Q3
1 quarter
ROCC
1215
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$8K ﹤0.01%
212
+35
+20% +$1.33K
2017 Q3
1 quarter
RNET
1216
DELISTED
RigNet, Inc.
RNET
$8K ﹤0.01%
+509
New +$8.23K
2017 Q4
0 quarters
MNTA
1217
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8K ﹤0.01%
+608
New +$8.22K
2017 Q4
0 quarters
XOXO
1218
DELISTED
Xo Group Inc
XOXO
$8K ﹤0.01%
413
+41
+11% +$797
2017 Q3
1 quarter
CMT icon
1219
Core Molding Technologies
CMT
$209M
$7K ﹤0.01%
338
+23
+7% +$507
2017 Q3
1 quarter
FONR icon
1220
DELISTED
Fonar
FONR
$7K ﹤0.01%
269
+65
+32% +$1.8K
2017 Q3
1 quarter
INBK icon
1221
First Internet Bancorp
INBK
$231M
$7K ﹤0.01%
187
-5
-3% -$187
2017 Q3
1 quarter
TTD icon
1222
Trade Desk
TTD
$5.64B
$7K ﹤0.01%
+1,510
New +$8.34K
2017 Q4
0 quarters
ARQ icon
1223
Arq
ARQ
$85.6M
$7K ﹤0.01%
679
+199
+41% +$2.12K
2017 Q3
1 quarter
JNCE
1224
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$7K ﹤0.01%
588
+82
+16% +$1.21K
2017 Q3
1 quarter
AUTO
1225
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$7K ﹤0.01%
798
-22
-3% -$180
2017 Q3
1 quarter

Similar funds

Royce & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Royce & Associates held 1,316 positions worth $15B, down 0.42% from $15.1B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Royce & Associates withdrew a net $674M in Q4 2017, closing 70 positions and reducing 600 holdings. Its most notable exit was Landauer Inc, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Verifone Systems Inc worth $11.2M.

  • Royce & Associates's largest Q4 2017 buy was Verifone Systems Inc: 629,800 shares worth $11.2M.
  • Royce & Associates added most to Fabrinet in Q4 2017, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2017 reduction was Cognex, cutting an estimated $64.3M.
  • Royce & Associates fully exited Landauer Inc in Q4 2017, selling an estimated $48.7M.
  • Royce & Associates's ten largest holdings make up 8.5% of its $15B portfolio in Q4 2017.
  • Royce & Associates opened 82 new positions and closed 70 in Q4 2017.
  • Royce & Associates's portfolio value fell 0.42% quarter-over-quarter to $15B.

Based on Royce & Associates's 13F filing for Q4 2017, filed 9 Feb 2018.